الصفحة الرئيسية>>3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g)

3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g)

رقم الكتالوجGA20393

Ellman's dihydropyran resin allows coupling primary and secondary as well as functionalized alcohols as acetal with high loading levels. The attachment functionality was stable to both strongly basic and nucleophilic reagents. Ellman's resin has been used within the synthesis of ketones from esters and biphenyltetrazole derivatives. Release of the product alcohol from the support is carried out by treating with 95% TFA / 5% water, TFA / CH?Cl? / EtOH or pyridinium p-toluenesulfonate / BuOH / 1,2-dichloroethane.

Products are for research use only. Not for human use. We do not sell to patients.

3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g) التركيب الكيميائي

الحجم السعر المخزون الكميّة
1g
172٫00
متوفر
5g
658٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ellman's dihydropyran resin allows coupling primary and secondary as well as functionalized alcohols as acetal with high loading levels. The attachment functionality was stable to both strongly basic and nucleophilic reagents. Ellman's resin has been u

مراجعات

Review for 3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g)

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.